388 related articles for article (PubMed ID: 27022964)
1. Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit.
Peirano GP; Mammana GP; Bertolino MS; Pastrana T; Vega GF; Russo J; Varela G; Vignaroli E; Ruggiero R; Armesto A; Camerano G; Dran G
Support Care Cancer; 2016 Aug; 24(8):3551-6. PubMed ID: 27022964
[TBL] [Abstract][Full Text] [Related]
2. Improved Pain Control in Terminally Ill Cancer Patients by Introducing Low-Dose Oral Methadone in Addition to Ongoing Opioid Treatment.
Fürst P; Lundström S; Klepstad P; Runesdotter S; Strang P
J Palliat Med; 2018 Feb; 21(2):177-181. PubMed ID: 28792784
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study.
Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J
Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912
[TBL] [Abstract][Full Text] [Related]
4. Opioid Rotation to Methadone for Refractory Cancer Pain: A Case Series.
Khoo SY; Aziz FA; Nambbiar P
J Pain Palliat Care Pharmacother; 2019; 33(3-4):125-130. PubMed ID: 31638444
[TBL] [Abstract][Full Text] [Related]
5. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
[TBL] [Abstract][Full Text] [Related]
6. First-line methadone for cancer pain: titration time analysis.
Mammana G; Bertolino M; Bruera E; Orellana F; Vega F; Peirano G; Bunge S; Armesto A; Dran G
Support Care Cancer; 2021 Nov; 29(11):6335-6341. PubMed ID: 33880639
[TBL] [Abstract][Full Text] [Related]
7. The role of methadone in cancer-induced bone pain: a retrospective cohort study.
Sulistio M; Wojnar R; Key S; Kwok J; Al-Rubaie Z; Michael N
Support Care Cancer; 2021 Mar; 29(3):1327-1335. PubMed ID: 32627056
[TBL] [Abstract][Full Text] [Related]
8. Methadone as a First-Line Opioid in Cancer Pain Management: A Systematic Review.
Mercadante S; Bruera E
J Pain Symptom Manage; 2018 Mar; 55(3):998-1003. PubMed ID: 29101087
[TBL] [Abstract][Full Text] [Related]
9. Methadone for cancer pain: what have we learned from clinical studies?
Soares LG
Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
[TBL] [Abstract][Full Text] [Related]
10. Dose ratios between high dose oral morphine or equivalents and oral methadone.
Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
[TBL] [Abstract][Full Text] [Related]
11. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
12. Practices, Attitudes, and Beliefs of Palliative Care Physicians Regarding the Use of Methadone and Other Long-Acting Opioids in Children with Advanced Cancer.
Madden K; Park M; Liu D; Bruera E
J Palliat Med; 2018 Oct; 21(10):1408-1413. PubMed ID: 29893627
[TBL] [Abstract][Full Text] [Related]
13. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
Mercadante S
Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
[TBL] [Abstract][Full Text] [Related]
14. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
[TBL] [Abstract][Full Text] [Related]
15. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
16. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
Zimmermann C; Seccareccia D; Booth CM; Cottrell W
J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
[TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
18. Methadone Dose Selection for Treatment of Pain Compared with Consensus Recommendations.
Karimian P; Atayee RS; Ajayi TA; Edmonds KP
J Palliat Med; 2017 Dec; 20(12):1385-1388. PubMed ID: 28609231
[TBL] [Abstract][Full Text] [Related]
19. Methadone titration in opioid-resistant cancer pain.
Scholes CF; Gonty N; Trotman IF
Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950
[TBL] [Abstract][Full Text] [Related]
20. Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit.
Mercadante S; Prestia G; Ranieri M; Giarratano A; Casuccio A
Support Care Cancer; 2013 Jul; 21(7):1853-9. PubMed ID: 23400316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]